Skip to main content
Explore URMC
menu

News

20202019201820172016

B&B Professor Harold Smith and Oyagen's Drug Development Highlighted on Local TV for World Aids Day

Friday, December 4, 2015

OyaGen, a small medical research firm off Jefferson Road in Henrietta, has used federal grants for its HIV drug discovery programs with the goal of finding a cure. Dr. Harold Smith, Professor of Biochemistry & Biophysics at the University of Rochester, and the company's founder, president and CEO got his start as a molecular biologist studying heart disease.

"It became clear to me that the things we were doing to study heart disease and find out why things were happening translated directly into the HIV research arena," Smith said.

By 2010, things kicked into high gear. Advanced robotics were added allowing scientists to work with advanced chemistries. They've now identified a weak point in the HIV virus that's never been exploited before. Vif is a viral defense HIV releases into cells it infects. It destroys the body's natural defense against infections. OyaGen discovered a way to defeat HIV by disabling Vif.

"If we can proceed along track, we will be looking at entering clinical trials within a completely different way of approaching the virus and the disease within three years," Smith said.

Alan Grossfield's Research Featured in Cosmos Article

Tuesday, September 1, 2015

Research performed by Associate Professor Alan Grossfield and colleagues into how a new class of drugs fights bacterial infections was highlighted in a recent Cosmos Magazine article. Dr. Grossfield's research was also recently highlighted in EurekaAlert!, an online magazine run by the American Association for the Advancement of Science.Read More: Alan Grossfield's Research Featured in Cosmos Article

B&B Department Mourns the Loss of Rose Burgholzer

Wednesday, June 24, 2015

It is with much sadness that we inform everyone of the passing of Rose Burgholzer, after a long and courageous battle with cancer. Rose worked at the University for 40 years, almost half of that as an administrator in our department. She was a dear friend and colleague and will be greatly missed. Many former students remember Rose fondly and have communicated with her during her illness, and she graciously received a steady stream of visiting faculty and staff in her home these past few years.

A Funeral Mass was held Wednesday, June 17, at St. Kateri at St. Margaret Mary Church in Rochester, with entombment at Holy Sepulchre Cemetery. Memorials may be directed to a charity of your choice. View her obituary and a slideshow from Rose's family.

Blocking Cellular Quality Control Mechanism Gives Cancer Chemotherapy a Boost

Friday, March 27, 2015

A University of Rochester team found a way to make chemotherapy more effective, by stopping a cellular quality-control mechanism, according to a study published today in Nature Communications.

The mechanism is known as NMD (nonsense-mediated mRNA decay), and scientists found that exposing breast cancer cells to a molecule that inhibits NMD prior to treatment with doxorubicin, a drug used to treat leukemia, breast, bone, lung and other cancers, hastens cell death.

The research team, led by Lynne E. Maquat, Ph.D., director of the Center for RNA Biology at the University of Rochester, acknowledges that the work is in the early stages and a long way from being applied in humans. But, they believe their data provide insights that could lead to new treatment strategies for cancer patients in the future.

Read More: Blocking Cellular Quality Control Mechanism Gives Cancer Chemotherapy a Boost

Lynne Maquat Receives 2015 Gairdner International Award

Thursday, March 26, 2015

Lynne E. Maquat, Ph.D. received the 2015 Gairdner International Award for the discovery and mechanistic studies of nonsense-mediated mRNA decay, a cellular quality control mechanism that derails the production of unwanted proteins in the body that can disrupt normal processes and initiate disease. She is one of five scientists honored with the award, which is given every year to recognize the achievement of medical researchers whose work contributes significantly to improving the quality of human life.

The J. Lowell Orbison Endowed Chair and Professor of Biochemistry and Biophysics at the University of Rochester Medical Center, Maquat is known around the world for her work on nonsense-mediated mRNA decay, which is critically important in both normal and disease states. She is considered the uncontested pioneer on the subject and in 2011 was elected to the National Academy of Sciences for her exceptional research, which has been published in more than 130 peer-reviewed scientific articles.

Maquat is the first scientist from upstate New York to receive the Gairdner International Award, which is recognized for its rigorous peer-led selection process. A panel of active Canadian scientists reviews all nominations and passes their recommendations to a board of two dozen senior scientists from across Canada, the United States, Europe, Australia and Japan. After in-depth study and review, board members cast votes for the nominees whose achievements rise above all others in their field. According to the Gairdner Foundation, of the 313 winners to date, 82 have gone on to receive a Nobel Prize in Physiology or Medicine, a testament to the quality of the awardees.

The award was also highlighted in the Opinion pages of Saturday’s Democrat and Chronicle in the Thumbs up, thumbs down section: Thumbs up: For Dr. Lynne Maquat, who is one of five biomedical researchers from around the world to win this year's Gairdner International Award. The University of Rochester Medical Center scientist has joined a prestigious group. Since 1959, more than a quarter of the Gairdner International winners have gone on to win a Nobel Prize, too.

Read More: Lynne Maquat Receives 2015 Gairdner International Award

B&B Graduate Students 'Bootleg' Their Way to the Top

Friday, March 20, 2015

The Pocket Radio Theater

The Biochemistry and Biophysics department is pleased to announce that a number of the department's graduate students have undertaken a very creative project. Specifically, six of our graduate students have been writing, producing, and voice acting in a serial podcast about bootleggers smuggling rum across Lake Ontario in 1921.

You can access the first three episodes on iTunes, or you can find them on their Pocket Radio Theater Facebook page. While contingent on their individual research workloads, their plan is to release more episodes on a monthly basis for a total of around 20.

Check out the creative endeavors of your departmental colleagues!

Department Announces Fred Sherman Student Award

Friday, March 6, 2015

The Department of Biochemistry & Biophysics are very pleased to announce a new student award within the Biochemistry and Molecular Biology program, to be given at our annual Awards Ceremony in May.

The Fred Sherman Award will honor the memory of our former colleague, and will annually recognize a student in the BMB program who exemplifies the imagination, the excellence in the pursuit of scientific knowledge, and the commitment to the scientific community that were characteristic of Fred Sherman.

This award will compliment the William F. Neuman Award, given annually to a BSCB student to recognize academic, scientific and personal qualities which exemplify the imagination, enthusiasm and excellence in the pursuit of scientific knowledge which were characteristic of the life of Dr. William F. Neuman.

MSTP Announces 40th Anniversary Celebration!

Sunday, February 1, 2015

Edward Rubin

Edward M. Eddy Rubin

The Medical Scientist Training Program (MSTP) is excited to announce a celebration of the 40th anniversary of the MSTP NIH training grant on Friday, October 9, 2015.

The keynote speaker will be an MSTP alumni from the Class of 1980: Edward Rubin, MD, PhD, Director, DOE Joint Genome Institute.

Edward M. Eddy Rubin is an internationally-known geneticist and medical researcher at the Lawrence Berkeley National Laboratory in Berkeley, California, where he became head of the Genomic Sciences Division in 1998. In 2002 he assumed the directorship of the DOE Joint Genome Institute (JGI) to lead the JGI's involvement in the Human Genome Project (HGP).

For more information and schedule of events for the day, please visit the MSTP 40th Anniversary page.